“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Related posts:
US Airspace To Crawl With 7,500 Drones In 5 Years
Guess where the country’s highest incomes are? Think government contractors. A great map.
With Cigarettes Banned In Most Prisons, Gangs Shift From Drugs To Smokes
WSJ: Five Reasons Why the Gold Bulls Are Right
ExxonMobil Hopes You’ve Forgotten About Mayflower, Arkansas
Ohio cop on paid leave after threatening handcuffed family with Taser
Montana Attorney General blames reporters for online threats against them
China Builds Great Central Bankers?
Seattle Mayor Orders Police to Dismantle Its Drone Program After Protests
Texas Governor Rick Perry Signs a Pair of Bills Upholding Fourth Amendment
Europe Continues to Circle the Drain
Zuckerberg: Facebook looking into how it can use cryptocurrency
Federal Over-Criminalization Task Force Formed
The Pentagon Is Hunting for UFOs. Guess How Much It Costs.
Excessive Criminal Laws Trap Honest American Businessman